Florida Eye Associates
Melbourne, Florida, United States
Ophthalmologist in Melbourne, Florida
509 E New Haven Ave, Melbourne, FL 32901
About Florida Eye Associates
"Florida Eye Associates is Brevard County's recognized leader in ophthalmology, providing families and seniors with quality eye care since 1967. Our board-certified team of ophthalmologists and optometrists provide comprehensive care from routine eye services to cataract and retinal surgery, LASIK surgery, and services for patients with low vision. We also offer a hearing center, a state of the art surgery center ASC of Brevard, and four convenient office locations in Melbourne, Cocoa Beach, Viera, and Palm Bay."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
16
Kodiak Sciences Inc
5
Genentech, Inc.
4
4D Molecular Therapeutics
1
AffaMed Therapeutics (US) Inc.
1
Allergan
1
Bayer
1
IVERIC bio, Inc.
1
Ionis Pharmaceuticals, Inc.
1
NGM Biopharmaceuticals, Inc
1
Ophthotech Corporation
1
Clinical Trials at Florida Eye Associates
During the past decade, Florida Eye Associates conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 12 clinical trials were completed, i.e. on
average, 38.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy
2012-05-29
2018-02-09
Terminated
159
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
2015-03-30
2017-06-02
Completed
96
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
2015-08-11
2017-09-26
Completed
273
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
2016-04-27
2017-12-14
Completed
229
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration
2017-01-27
2018-03-29
Completed
76
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
2017-09-21
2018-11-20
Completed
28
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Florida Eye Associates" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Kodiak Sciences Inc" with 5 trials
sponsored, "Genentech, Inc." with 4 trials sponsored, "4D Molecular Therapeutics" with 1 trials sponsored and "AffaMed Therapeutics (US) Inc."
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Eye Associates"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Florida Eye Associates
According to Clinical.Site data, the most researched conditions in "Florida Eye Associates" are
"Geographic Atrophy" (9 trials), "Diabetic Macular Edema" (5 trials), "Macular Edema" (3 trials), "Neovascular Age-Related Macular Degeneration" (3 trials) and "Macular Degeneration" (2 trials). Many other conditions were trialed in "Florida Eye Associates" in a lesser frequency.
Clinical Trials Intervention Types at Florida Eye Associates
Most popular intervention types in "Florida Eye Associates" are "Drug" (29 trials), "Other" (13 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (13 trials), "Faricimab" (9 trials), "Aflibercept" (8 trials), "KSI-301" (5 trials) and "Lampalizumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Florida Eye Associates
The vast majority of trials in "Florida Eye Associates" are
33 trials for "All" genders.
Clinical Trials Status at Florida Eye Associates
Currently, there are NaN active trials in "Florida Eye Associates".
undefined are not yet recruiting,
5 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Florida Eye Associates,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Florida Eye Associates, 4 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".